Bimatoprost NDC 68071-3590

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-3590Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-3590Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-3590-5	68071359005	1 BOTTLE in 1 CARTON (68071-3590-5) / 2.5 mL in 1 BOTTLEMarketed from Mar 25, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bimatoprost
Generic name (nonproprietary): bimatoprost
Active ingredients: Bimatoprost — .3 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210126
Marketing start: Aug 10, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Prostaglandins (Chemical structure)
Identifiers: Product ID 68071-3590_147e1501-382d-e443-e063-6294a90ac5a8SPL ID 147e1501-382d-e443-e063-6294a90ac5a8SPL set ID 147e2ec6-8fb1-ed5a-e063-6294a90a5ecaRxCUI 308739UNII QXS94885MZUPC 0368071359053
Pharmacologic class: Prostaglandin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071359005 followed by a unit qualifier and the quantity

Package 68071-3590-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 25, 2024.

Indications (excerpt from the label)

Bimatoprost ophthalmic solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Bimatoprost ophthalmic solution, 0.03% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210126

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210126
Product	Strength	Form · route	Labeler	Product NDC
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Fosun Pharma USA Inc.	72266-140
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Fosun Pharma USA Inc.	72266-139
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Fosun Pharma USA Inc.	72266-241
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-295
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-296
Bimatoprost	Bimatoprost .3 mg/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-439